MX2021010193A
(en )
2021-09-21
Azepino-indoles and other heterocycles for treating brain disorders.
MX2023004593A
(en )
2023-05-08
Tyk2 inhibitors and uses thereof.
CY1121359T1
(en )
2020-05-29
HETEROYARLY COMPOUNDS FOR MOTION SUSPENSION
GEP20247593B
(en )
2024-02-12
Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
CL2022000448A1
(en )
2022-11-18
Autoinjector (divisional application no. 201903061)
MX2019013072A
(en )
2019-12-16
Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies.
MX2020003425A
(en )
2020-07-29
Treatment of inflammatory disorders.
MX2019003623A
(en )
2019-09-23
Compositions and methods for treating ophthalmic conditions.
MX2018008105A
(en )
2018-11-12
Metalloenzyme inhibitor compounds.
MX2018008815A
(en )
2019-03-28
Bruton's tyrosine kinase inhibitors.
MX2021003450A
(en )
2021-07-16
Methods of treating myeloproliferative disorders.
EA201890185A1
(en )
2018-07-31
METHODS OF TREATMENT OF DISEASES MEDIATED BY GEPSID
MX2018016057A
(en )
2019-05-06
Compositions and methods for treating cardiovascular disease.
PH12018500887A1
(en )
2018-10-29
Anti-htra1 antibodies and methods of use thereof
MX2019011116A
(en )
2020-02-05
Bruton's tyrosine kinase inhibitors.
EA201792604A1
(en )
2018-04-30
AUTOTAXIN INHIBITORS AND THEIR APPLICATIONS
MX2018009325A
(en )
2019-05-15
Compounds and methods of treating rna-mediated diseases.
MX2020004666A
(en )
2022-01-26
Compositions and methods for the treatment of eye disorders.
PH12019500751A1
(en )
2019-08-05
Carbamoyl phenylalaninol compounds and uses thereof
EA201990400A1
(en )
2019-07-31
COMPOUNDS AND COMPOSITIONS AND THEIR APPLICATION
MX2018006700A
(en )
2019-02-20
Aza-benzimidazole inhibitors of pad4.
MX2021005394A
(en )
2021-07-06
Co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies.
PH12020551336A1
(en )
2021-12-13
Anti-klk5 antibodies and methods of use
EA202191086A1
(en )
2021-09-20
COMBINED MELANOMA THERAPY
EA201790893A1
(en )
2018-01-31
METHODS OF TREATMENT OF OPHTHALMOLOGICAL DISORDERS